Epigenetic mechanisms as a new approach in cancer treatment: An updated review

被引:150
|
作者
Fardi, Masoumeh [1 ,4 ]
Solali, Saeed [2 ,3 ]
Hagh, Majid Farshdousti [5 ]
机构
[1] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Mol Med Res Ctr, Tabriz, Iran
[3] Tabriz Univ Med Sci, Hematol & Oncol Res Ctr, Tabriz, Iran
[4] Tabriz Univ Med Sci, Div Hematol & Blood Transfus Med, Dept Immunol, Tabriz, Iran
[5] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
关键词
Cancer; Epigenetic; Mechanisms; Treatment; Methylation; DNA METHYLATION INHIBITORS; PROMOTER METHYLATION; DNMT3A MUTATIONS; SOLID TUMORS; DEMETHYLATION; EXPRESSION; CHROMATIN; GENES; EZH2; HYPERMETHYLATION;
D O I
10.1016/j.gendis.2018.06.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epigenetic, along with genetic mechanisms, is essential for natural evolution and maintenance of specific patterns of gene expression in mammalians. Global epigenetic variation is inherited somatically and unlike genetic variation, it is dynamic and reversible. They are somatically associated with known genetic variations. Recent studies indicate the broad role of epigenetic mechanisms in the initiation and development of cancers, that they are including DNA methylation, histone modifications, nucleosomes changes, non-coding RNAs. The reversible nature of epigenetic changes has led to the emergence of novel epigenetic therapeutic approaches, so that several types of these medications have been approved by the FDA so far. In this review, we discuss the concept of epigenetic changes in diseases, especially cancers, the role of these changes in the onset and progression of cancers and the potential of using this knowledge in designing novel therapeutic strategies. Copyright (C) 2018, Chongqing Medical University. Production and hosting by Elsevier B.V.
引用
收藏
页码:304 / 311
页数:8
相关论文
共 50 条
  • [31] Mechanisms of exercise in the treatment of lung cancer - a mini-review
    Luo, Zhiwen
    Wan, Renwen
    Liu, Shan
    Feng, Xinting
    Peng, Zhen
    Wang, Qing
    Chen, Shiyi
    Shang, Xiliang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [32] Review of Mechanisms and Treatment of Cancer-Induced Cardiac Cachexia
    Vudatha, Vignesh
    Devarakonda, Teja
    Liu, Christopher
    Freudenberger, Devon C.
    Riner, Andrea N.
    Herremans, Kelly M.
    Trevino, Jose G.
    CELLS, 2022, 11 (06)
  • [33] Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment
    Zagni, C.
    Chiacchio, U.
    Rescifina, A.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (02) : 167 - 185
  • [34] Epigenetic control of gene expression: Potential implications for cancer treatment
    Perri, F.
    Longo, F.
    Giuliano, M.
    Sabbatino, F.
    Favia, G.
    Ionna, F.
    Addeo, R.
    Scarpati, G. Della Vittoria
    Di Lorenzo, G.
    Pisconti, S.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 111 : 166 - 172
  • [35] Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms
    Fath, Mohsen Karami
    Babakhaniyan, Kimiya
    Anjomrooz, Mehran
    Jalalifar, Mohammadrasoul
    Alizadeh, Seyed Danial
    Pourghasem, Zeinab
    Oshagh, Parisa Abbasi
    Azargoonjahromi, Ali
    Almasi, Faezeh
    Manzoor, Hafza Zahira
    Khalesi, Bahman
    Pourzardosht, Navid
    Khalili, Saeed
    Payandeh, Zahra
    VACCINES, 2022, 10 (09)
  • [36] An Updated Review of Disulfiram: Molecular Targets and Strategies for Cancer Treatment
    Yang, Qingzhu
    Yao, Yao
    Li, Kai
    Jiao, Lin
    Zhu, Jiazhen
    Ni, Cheng
    Li, Mengmeng
    Dou, Q. Ping
    Yang, Huanjie
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (30) : 3248 - 3256
  • [37] A global assessment of cancer genomic alterations in epigenetic mechanisms
    Shah, Muhammad A.
    Denton, Emily L.
    Arrowsmith, Cheryl H.
    Lupien, Mathieu
    Schapira, Matthieu
    EPIGENETICS & CHROMATIN, 2014, 7
  • [38] Epigenetic Alterations and MicroRNA Misexpression in Cancer and Autoimmune Diseases: a Critical Review
    Saito, Yoshimasa
    Saito, Hidetsugu
    Liang, Gangning
    Friedman, Jeffrey M.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2014, 47 (02) : 128 - 135
  • [39] Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment
    Berndsen, Robert H.
    Abdul, U. Kulsoom
    Weiss, Andrea
    Zoetemelk, Marloes
    te Winkel, Marije T.
    Dyson, Paul J.
    Griffioen, Arjan W.
    Nowak-Sliwinska, Patrycja
    ANGIOGENESIS, 2017, 20 (02) : 245 - 267
  • [40] Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment
    Robert H. Berndsen
    U. Kulsoom Abdul
    Andrea Weiss
    Marloes Zoetemelk
    Marije T. te Winkel
    Paul J. Dyson
    Arjan W. Griffioen
    Patrycja Nowak-Sliwinska
    Angiogenesis, 2017, 20 : 245 - 267